Mercy Research - David C. Pratt Cancer Center ( Site 2532) — St Louis, Missouri

Mercy Research - David C. Pratt Cancer Center ( Site 2532) is a clinical research site located in St Louis, Missouri, United States 63109.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mercy Research - David C. Pratt Cancer Center ( Site 2532) has participated in 1 clinical trials.

Therapeutic areas: Metastatic Non Small Cell Lung Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mercy Research - David C. Pratt Cancer Center ( Site 2532)?

Mercy Research - David C. Pratt Cancer Center ( Site 2532) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mercy Research - David C. Pratt Cancer Center ( Site 2532) conducted?

Mercy Research - David C. Pratt Cancer Center ( Site 2532) has 1 clinical trials on record. Their work covers Metastatic Non Small Cell Lung Cancer.

Is Mercy Research - David C. Pratt Cancer Center ( Site 2532) accredited by Crixeo Health?

Mercy Research - David C. Pratt Cancer Center ( Site 2532) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mercy Research - David C. Pratt Cancer Center ( Site 2532)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.